These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10579825)

  • 1. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth.
    Vippagunta SR; Dorn A; Matile H; Bhattacharjee AK; Karle JM; Ellis WY; Ridley RG; Vennerstrom JL
    J Med Chem; 1999 Nov; 42(22):4630-9. PubMed ID: 10579825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of chloroquine-hematin mu-oxo dimer binding by isothermal titration calorimetry.
    Vippagunta SR; Dorn A; Ridley RG; Vennerstrom JL
    Biochim Biophys Acta; 2000 Jul; 1475(2):133-40. PubMed ID: 10832027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine: stimulation of hematin polymerization and antagonism of its inhibition by chloroquine.
    Vippagunta SR; Dorn A; Bubendorf A; Ridley RG; Vennerstrom JL
    Biochem Pharmacol; 1999 Sep; 58(5):817-24. PubMed ID: 10449192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.
    Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ
    Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon isosteres of the 4-aminopyridine substructure of chloroquine: effects on pK(a), hematin binding, inhibition of hemozoin formation, and parasite growth.
    Cheruku SR; Maiti S; Dorn A; Scorneaux B; Bhattacharjee AK; Ellis WY; Vennerstrom JL
    J Med Chem; 2003 Jul; 46(14):3166-9. PubMed ID: 12825955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
    Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
    ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity.
    Egan TJ; Hunter R; Kaschula CH; Marques HM; Misplon A; Walden J
    J Med Chem; 2000 Jan; 43(2):283-91. PubMed ID: 10649984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structures of chloroquine-ferriheme complexes modeled using MD simulation and investigated by EXAFS spectroscopy.
    Kuter D; Streltsov V; Davydova N; Venter GA; Naidoo KJ; Egan TJ
    J Inorg Biochem; 2016 Jan; 154():114-25. PubMed ID: 26088729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position.
    Kaschula CH; Egan TJ; Hunter R; Basilico N; Parapini S; Taramelli D; Pasini E; Monti D
    J Med Chem; 2002 Aug; 45(16):3531-9. PubMed ID: 12139464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-Aminoquinolines active against blood stage Plasmodium falciparum in vitro inhibit hematin polymerization.
    Vennerstrom JL; Nuzum EO; Miller RE; Dorn A; Gerena L; Dande PA; Ellis WY; Ridley RG; Milhous WK
    Antimicrob Agents Chemother; 1999 Mar; 43(3):598-602. PubMed ID: 10049273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel short chain chloroquine analogues retain activity against chloroquine resistant K1 Plasmodium falciparum.
    Stocks PA; Raynes KJ; Bray PG; Park BK; O'Neill PM; Ward SA
    J Med Chem; 2002 Nov; 45(23):4975-83. PubMed ID: 12408708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling and UV-vis spectroscopic studies on the mechanism of action of reversed chloroquine (RCQ).
    Otelo VA; Sant'Ana AC; de Faria DL; Menezes CM
    Bioorg Med Chem Lett; 2011 Jan; 21(1):250-4. PubMed ID: 21095121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of hematin by the antimalarial pyronaridine.
    Auparakkitanon S; Chapoomram S; Kuaha K; Chirachariyavej T; Wilairat P
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2197-200. PubMed ID: 16723583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resonance Raman spectroscopy can detect structural changes in haemozoin (malaria pigment) following incubation with chloroquine in infected erythrocytes.
    Webster GT; Tilley L; Deed S; McNaughton D; Wood BR
    FEBS Lett; 2008 Apr; 582(7):1087-92. PubMed ID: 18325340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and antiplasmodial activity of novel imidazole derivatives based on 7-chloro-4-aminoquinoline.
    Kondaparla S; Manhas A; Dola VR; Srivastava K; Puri SK; Katti SB
    Bioorg Chem; 2018 Oct; 80():204-211. PubMed ID: 29940342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-N-, 4-S-, and 4-O-chloroquine analogues: influence of side chain length and quinolyl nitrogen pKa on activity vs chloroquine resistant malaria.
    Natarajan JK; Alumasa JN; Yearick K; Ekoue-Kovi KA; Casabianca LB; de Dios AC; Wolf C; Roepe PD
    J Med Chem; 2008 Jun; 51(12):3466-79. PubMed ID: 18512900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance.
    Warhurst DC; Craig JC; Raheem KS
    PLoS One; 2016; 11(8):e0160091. PubMed ID: 27483471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of antimalarial action of [Au(CQ)(PPh(3))]PF(6): structural effects and increased drug lipophilicity enhance heme aggregation inhibition at lipid/water interfaces.
    Navarro M; Castro W; Martínez A; Sánchez Delgado RA
    J Inorg Biochem; 2011 Feb; 105(2):276-82. PubMed ID: 21194628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.
    Olafson KN; Ketchum MA; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):4946-51. PubMed ID: 25831526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to hematin: the basis of chloroquine resistance.
    Bray PG; Mungthin M; Ridley RG; Ward SA
    Mol Pharmacol; 1998 Jul; 54(1):170-9. PubMed ID: 9658203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.